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Abstract: Several studies have reported that nature-derived antioxidants may prevent free radicals over-production and therefore
control the onset and prevent the exacerbation of different kinds of diseases caused by oxidative stress and redox-derived stres-
sors, including ageing, fundamentally by suppressing the oxidative by-products-mediated degradation. Naturally derived antioxi-
dants exert their anti-ageing action via a panoply of signalling systems, many of which engaging reactive oxygen and nitrogen
species scavenging, with the Nrf2/Keap1-ARE system and improving the many survival genes and functions (such as the path-
way mTOR/Foxo/SIRT1) able to slow cellular senescence. Most of the research in this field has evaluated the regulative effects
and even pathways of herbal extracts with antioxidant property in the ageing process, and various age-related disorders such as
cardiovascular disease, ischaemia-reperfusion injury, coronary and myocardial circulatory perfusion, peripheral vascular resis-
tance, and even neurodegenerative disorders are prevented plant phytochemicals often via their antioxidant potential. A much
more complex ability to interact with survival functions makes these compounds successfully active in preventing ageing-related
disorders. This report aimed to discuss in more detail some selected medicinal plants including Allium sativum, Aloe vera,
Crataegus spp., Cynara scolymus, Eleutherococcus senticosus, Ginkgo biloba, Hippophae rhamnoides, Panax ginseng, Rosmari-
nus officinalis, Schizandra chinensis, Vitis vinifera and seaweeds in the prevention of ageing-related pathologies. A systematic
overview of the relevant information in the antioxidant function of the many herbal products reviewed here for the control of the
ageing process is proposed, to provide a new horizon on the design of anti-ageing herbal medicines.
Destructive and progressive modifications in one or more tis-
sues lead to organs impairment function and consequently to
ageing, which over time cause disease and in last instance
death [1]. The ageing process is an unavoidable pathway
directly influenced by lifestyle, genetic and environmental fac-
tors [2], and a process that briefly involves the acceleration of
destructive modifications over time, both at the cellular and
molecular levels [3]. Moreover, ageing process is also corre-
lated with immune system dysfunction, nervous system
impairment and apoptosis [4]. Different studies have found
that the induction of apoptosis is related to a decrease in glu-
tathione (GSH) levels and elevated oxidative stress in brain
and liver tissues [4,5]. In fact, the relationship of apoptosis
with ageing and cellular senescence is much more complex
and can highlight some of the anti-ageing effects described for
phytochemicals [6]. The oxidation process is a natural and
pivotal process of the body, besides to be also destructive, as
it can bear noxious damage. Cells produce, in a continuous
manner, free radicals and reactive oxygen (ROS) and nitrogen
(RNS) species as part of the metabolic processes [7]. Those
molecules are unpaired electrons released by biochemical pro-
cesses in the body, which are formed when the body uses
oxygen to metabolize nutrients (i.e., fats and carbohydrates).
However, they can also be produced due to stress, radiation,
infections and smoking exposure [8–12]. Considered extre-
mely harmful to the body, these highly reactive molecules
favour the appearance of numerous damages in organic bio-
molecules (i.e. nucleic acids, lipids and proteins), induce DNA
changes, which in turn affect the organic homeostasis of the
body, and can lead to several oxidative stress-related disorders,
such as cardiovascular and other degenerative disorders, and
even cancer [13,14]. Moreover, oxidative stress reflects an
imbalance between the antioxidant system and oxidants in the
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body [5]; that is, it can also impair cell membranes function
and consequently induce irreversible damages, which culmi-
nates with cell death and/or triggering of age-related chronic
diseases, such as Alzheimer’s, Parkinson’s, arthritis,
atherosclerosis, osteoporosis, dementia, cardiovascular diseases
and cancer [15]. The mechanism underlying ROS scavenging
involves not only detoxifying enzymes but also the much
more complex signalling pathway Nrf2/Keap1/ARE. Usually,
this master tuner of oxidative stress is related to further cell
sensors, such as the hypoxia-inducible factor (HIF-1a), which
activates a broad panoply of genes against the hypoxic injury,
being this activity regulated by the intracellular oxygen sen-
sors prolyl hydroxylases (PHDs) [16]. Cells possess at least
three different isoforms of PHDs, that is PHD 1–3. The PHD-
1 gene silencing induces hypoxic tolerance and shift cell func-
tion to reprogramme mitochondrial oxygen consumption,
through decreasing ROS production also in hypoxic mitochon-
dria [16]. When the antioxidant machinery should be activated
to remove ROS, the nuclear factor-erythroid 2 p45-related fac-
tor 2 (Nrf2) via the intracellular sensor Kelch-like ECH-asso-
ciated protein 1 (Keap1) regulates the basal and inducible
expression of numerous antioxidant stress genes. The tran-
scription factor Nrf2 (NF-E2-related factor 2) plays a vital role
in maintaining cellular homeostasis, especially upon the expo-
sure of cells to chemical or oxidative stress, through its ability
to regulate the basal and inducible expression of a multitude
of antioxidant proteins, detoxification enzymes, and xenobiotic
transporters. The activity of Nrf2 is primarily regulated via its
interaction with Keap1 (Kelch-like ECH-associated protein 1),
which directs the transcription factor for proteasomal degrada-
tion. Phytochemicals are also good activators of the Nfr2
activity [17–19], and this ability makes phytochemicals able to
prevent cell ageing-related disorders [20–23]. In this sense, the
indirect antioxidant activity of natural products resulting in the
production cytoprotective proteins (phase 2 enzymes) and
endogenous direct antioxidants seems to be more important
than their direct antioxidant activity.
The improvement of life expectancy and the delay of ageing
process have deserved special relevance since ancient times
but recently gained pivotal attention, being the maintenance of
health and well-being of human individuals crucial. In fact,
numerous studies have emphasized that free radicals and ROS/
RNS over-production represent a suitable environment for the
development of age-related diseases [24,25]. Furthermore, it
has also been shown that reduced levels of antioxidant mole-
cules or even a limiting bioavailability of antioxidant enzymes
improves oxidative stress, leading to cellular destruction
[26,27]. The different multifaceted aspects of ageing and cellu-
lar senescence are intriguing targets for multiple natural sub-
stances coming from plants, due to their well-known
pleiotropism. Their activity targets not only the complex
antioxidant and enzyme-mediated ROS and RNS scavenging
system, but also many other pathways involved in energy bal-
ance and ageing, such as AMPK/mTOR/Foxo-1/sirtuin 1 sys-
tem [28,29]. The antioxidant activity achieved by eliciting
antioxidant enzymes or even acting directly on biological
nucleophiles may also explain, to some extent, the anti-
inflammatory and cytotoxic activity of these compounds. Over
the years, an increasing interest in the use of natural sub-
stances, including some questions related to the safety of syn-
thetic compounds, has been highlighted, which encourages the
development of more and increasingly detailed studies through
using plant-derived resources [30,31]. The assessment of the
bioactive potential of natural products, namely herbal products
and its derived preparations, has also received increasing atten-
tion, as some of them were already considered excellent anti-
ageing agents and health promoters [32]. Plants and animals
have complex antioxidant systems, which act as effective pro-
tectors against invaders or even slow down the oxidation
induced by multiple chemical substances. Commonly known as
endogenous antioxidants, enzymes such as superoxide dismu-
tase (SOD), catalase (CAT), glutathione peroxidase (GPx), and
numerous non-enzymatic antioxidants, including vitamins C
and E, beta-carotene, ubiquinone, trace elements zinc and sele-
nium, GSH, lycopene, lutein and flavonoids, are among the
most prominent and efficient ones [33]. However, with the mag-
nitude of oxidative stress reactions, endogenous antioxidants are
limiting, and therefore, other alternatives need to be found to
improve and even to complement the organic protection.
There are two sources of antioxidants: antioxidative
enzymes are mainly found in and around cells, while exoge-
nous antioxidants have been primarily obtained through fruits
and vegetables, nuts, berries, red wine, green tea and ulti-
mately dietary supplements [34,35]. The activity of many of
these plant-derived natural products is to tune the existing
interplay between the mitochondria-endoplasmic reticulum
(ER)-proteasome with cell ability in controlling apoptosis/au-
tophagy and survival functions [36]. On the other hand, some
of the major chronic diseases related to ageing such as arthri-
tis, atherosclerosis, osteoporosis, cardiovascular diseases and
dementia are linked to inflammation, and therefore, inflamma-
tory processes may be considered a potential pathway, is trig-
gering molecular modifications and worsening pathological
processes, in which flavonoids are major anti-inflammatory
molecules, able to inhibit the pro-inflammatory role of NF-jB
[37,38]. Although several studies have been performed in this
field, a general overview elucidating the most efficient and
promissory plant-derived phytochemicals with anti-ageing abil-
ities is still relatively restricted [2]. Thus, the objective of the
present report was to provide an extensive knowledge regard-
ing the different possibilities based on the use of medicinal
plants for anti-ageing purposes (table 1). The different roles of
bioactive constituents were also included as also their con-
tributive role in ageing regulation.
Medicinal Plants for Ageing: Which Ones?
Herbal remedies have been again more readily accepted than
the synthetic alternatives by worldwide consumers, after a per-
iod in which natural resources became secondary [39]. Herbal
formulations comprise an ancient practice being even consid-
ered the first choice for treating adaptive and functional age-
ing-related disorders [40]. It is tempting to speculate that
herbal preparations might be effectively used in the field of
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holistic gerontotherapeutics, that is, therapeutic management,
carefully designed to retard the sudden drop in performance,
quite frequently after the sixth decade of life. Herbal medicine
often retrieves its ability to prevent pathology from folk tradi-
tions, and a long, millenarian empirical expertise, but, anyway,
modern pharmacology appears to assess and confirm some of
these beliefs. Currently, traditional herb remedies have gained
special relevance, up to the point that has been considered
potential candidates for the management and even treatment of
chronic and ageing-related diseases [41–43]. Taking into
Table 1.
Selected medicinal plants with active anti-ageing properties.
Plants Parts used and main components Therapeutic effects Mechanisms of action References
Allium sativum
Liliaceae (Garlic)
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account such examples, it is convenient to highlight the results
of several studies, which suggests that ‘anti-ageing herbs’
exert multifunctional effects and can protect the whole body
through different mechanisms [44]. Further, other lines of
research have also reported that those matrices are potential
candidates to prevent and/or even to treat multiple ageing-
related neurological disorders [32,45]. In fact, most of the cur-
rently available chemical drugs derive, directly or indirectly,
from natural compounds, playing therefore a great contribution
to drug discovery and development [46–48]. Many of these
herbs and their main active principles (flavonoids) are shown
in fig. 1.
Major Medicinal Plants Used in Medication System as
Anti-Ageing Agent
The World Health Organization (WHO) reported that at least
three-quarter of the world population uses medicinal herbs for
their health care. Actually, remarkable research papers about
medicinal plants deal with pharmacognosy, chemistry, pharma-
cology and clinical therapeutics of Ayurveda and Chinese
therapeutic systems [49]. Current knowledge demonstrated that
the main factors of inflammatory processes could occur via
dysregulated gene expression under the age-related oxidative
stress as well as through induction of redox-sensitive transcrip-
tion factors. Important agents contributed to the inflammatory
pathways are those of age-related up-regulation, such as NF-
jB, IL-1b, IL-6, TNF-a, cyclooxygenase-2, adhesion mole-
cules and inducible NO synthase [37,50,51].
Allium sativum L. (English name: Garlic; Family: Alliaceae).
Garlic is considered an active and efficient anti-ageing agent
[52–56]. A direct influence of garlic on atherosclerosis was
already discussed [57–60], and their anti-atherosclerotic
effect attributed to its hypolipaemic activity [61]. Experi-
mental and clinical data have demonstrated that garlic
reduces blood cholesterol levels [62–64], dementia and risk
of heart disease [65], homocysteine levels [66], hypertension
[64,67], as well as inflammation [68]. Ajoene (4,5,9-trithia-
dodeca-1,6,11-triene 9-oxide) is the main active principle of
garlic. Its anti-inflammatory potential has been reported as
inhibiting the quorum sensing (QR) system of some bacte-
ria, such as Pseudomonas aeruginosa, which use this mech-
anism to synchronize the expression of specific genes
involved in pathogenicity [69]. The role of garlic as an
anti-ageing natural product has been particularly stressed in
recent years [70–73]. In fact, the major effect of garlic on
Table 1. (continued)


































quercitrin, rutin, phenolic acids
and lignans
Hepatoprotective from oxidative
damage, stimulation of caspase-
dependent apoptosis in human
cancer cells, alleviate cognition
disorders and attenuate












acid, chlorogenic acid, caffeic
acid, myricetin and quercetin
Liver diseases, swelling, cysts,

















© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
542 GEIR BJØRKLUND ET AL. MiniReview
ageing-related disorder has been demonstrated in both
atherosclerosis and inflammation.
Besides their activity in bacteria, garlic also exerts a benefi-
cial effect on further disorders related to ageing, such as
atherosclerosis. Treatment during 4 years with a standardized
garlic-based drug, such as 900 mg garlic powder (Kwai),
could decrease 5–18% volume of atherosclerotic plaques in
femoral and carotid arteries [74]. The association between
increased age and the volume of plaque showed an elevation
between 50 and 80 years, which garlic treatment reduced by
6–13% over 4 years. Therefore, using garlic, the volume of
plaque remained practically constant for the age span of 50
and 80 years [75]. The activity of many allyl sulphides in gar-
lic might give insight on its activity towards DNA. For
Fig. 1. The main flavonoids contained in different medicinal plant extracts. Quite almost of these sources are rich in luteolin, which is present in
most of the indicated plants, besides quercetin, catechins and apigenin. Black curve arrows indicate the major isolated flavone-derived compounds
and blue arrows the major phytochemical classes.
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example, both diallyl sulphide and diallyl disulphide inhibit
the DNA damage induced by aflatoxin B1 in rat hepatocytes,
increasing gene expression repair and hepatocyte viability,
enhancing intracellular glutathione-S-transferase (GST) [76].
The effect of these allyl sulphides has been reported to modu-
late oxidized LDL (ox-LDL)-mediated adhesion on endothelia
by leucocytes via protein kinase A (PKA) and protein kinase
B (PKB) signalling pathways [77].
A meta-analysis carried out by Silagy et al. [78] reviewed
the effects of Bulbus Allii sativi on lipoproteins and serum
lipids. Sixteen of the 25 randomized controlled trials they
reviewed were selected, which provide data for 952 individu-
als [78]. Of these studies, 14 were parallel group trials, and
two were crossover studies. Twelve of these studies were dou-
ble-blind, two were single-blind, and two were open-label
studies. Those studies investigated the efficacy of garlic pre-
pared in different formulations including in dried powder
(600–900 mg), raw form (10 g), oil form (18 mg) or aged
garlic extracts with the median duration of therapy of
12 weeks. In summary, an average of 12% reduction in total
cholesterol upon receiving garlic supplementation in either
powder or non-powder form was observed, while 13% reduc-
tion in serum triglycerides was observed in groups receiving
garlic supplementation in powdered form [78]. The clinical
data reported by Silagy and Neil [78] in the meta-analysis well
supported the notion that garlic therapy is effective in lipid-
lowering action. Moreover, similar results of potential lipid-
lowering for preparations of dry garlic powder have been
reported in other studies [79–81]. Thus, a daily dose of 600–
900 mg garlic powder proved to be effective to significantly
decrease triglyceride and serum cholesterol levels [79,82].
Another study showed that garlic extract exerted neuroprotec-
tive effects on cognitive dysfunction and neuroinflammation
through decreasing the activation of microglia and IL-1b to
basal levels [83]. Numerous biological effects of garlic,
including antimicrobial, antioxidant, antidiabetic, anticarcino-
genic, antimutagenic, anti-atherosclerotic and immunomodula-
tory activities have been recently documented, and many of
them are related with ageing-dependent disorders [3,84,85].
Garlic as well-known medicines worldwide could be adminis-
tered in the public herbal medication [86].
Aloe vera (L.) Burm.f. (English names: Barbados Aloes, Bitter
Aloe, Curacao Aloe; Family: Aloaceae).
The Aloe vera plant possesses very interesting anti-ageing and
microcirculatory stimulant effects [52]. Components of Aloe
vera have been recently analysed [87]. One of its major com-
ponents, emodin, has been reported to inhibit type 2 diabetes-
dependent neuropathic pain in rat models by decreasing the
excitatory transmitting activity of the P2X3 receptor in the
dorsal root ganglia [88]. Clinical studies demonstrated that
preparation and administration of aloe vera gel could stimulate
wound healing [89]. Previous studies have revealed that aloe
vera gel was able to prevent progressive dermal ischaemia due
to several kinds of trauma, including burns, electrical injury,
intra-arterial drug abuse and frostbite [90–92]. An in vivo
study using aloe vera gel demonstrated a thromboxane A2
inhibitor effect that could suppress the progression of tissue
damage induced by thromboxane A2 [93,94]. Besides that,
there are also several other mechanisms that have been
increasingly proposed to elucidate the mechanism of action of
aloe vera gel in wound healing, such as providing hydration,
insulation and protection, as well as stimulating the compli-
ment linked to polysaccharides [95,96]. Moreover, aloe vera
gel was also able to promote wound healing mediated through
in vivo stimulation of macrophages and fibroblasts activity. It
is known that the activation of fibroblast has been associated
with enhancement of collagen and proteoglycan synthesis,
subsequently to support tissue repair [95,97]. Based on the
currently available literature, approximately 75 potentially
active ingredients were already proposed to be responsible for
the observed effects; among them are vitamins, enzymes, min-
erals, sugars, lignin, saponins, salicylic acids and amino acids
[96,98]. Wound healing is one of the possible concerns in
repairing trauma during ageing. Furthermore, some of the
active principles have been identified as polysaccharides,
which are composed of several monosaccharides, predomi-
nantly mannose [96,99,100]. As the main sugar component in
aloe vera gel, mannose 6-phosphate has been suggested to
play an important role in the wound healing properties of the
gel. Studies reported that mannose 6-phosphate enhances
fibroblasts activity through binding to the growth factor recep-
tors present on the surface of cells [95]. Similarly,
mucopolysaccharides isolated from Aloe vera was also found
to improve the anti-ageing effect through induction of fibrob-
last activity that makes elastin and collagen fibres more
strengthful, resulting in less wrinkled and more elastic skin
[101]. Aloes exert their anti-ageing effects mainly through the
modulation and scavenging of ROS contents [102,103]. Aloe-
derived emodin exerts its antioxidant and pro-apoptotic effect
(e.g., in cancer cells) via the Nfr2-mediated signalling [104].
Also, it was reported that Aloe vera extract could induce con-
siderable improvements in decreased CAT, SOD, GSH, GPx
and glutathione-S-transferase levels in liver and kidney of dia-
betic rats, suggesting their immunomodulatory and antioxidant
effects [105,106]. For certain aspects, Aloe vera’s antioxidant
activity seems to be strictly correlated with their anti-inflam-
matory, free radicals- and superoxide radical-scavenging
effects, that is through reducing the production of prostaglan-
din E2 from arachidonic acid, inactivation of different tran-
scription factors and even the activity of several enzymes,
such as cyclooxygenase and lipoxygenase [98]. Besides, the
antioxidant potency of polysaccharides from Aloe vera against
doxorubicin (DOX)-induced myocardial oxidative stress in
albino Wistar rats has also been shown, thus reporting insight-
ful data about the cardiovascular disorders often related to
aged individuals [107]. Aloe vera gel and latex have shown to
present therapeutic effects and health management benefits,
through exerting antitumour, antioxidant and anti-inflamma-
tory activities. This activity enables Aloe vera extracts to exert
potential benefits on many ageing-related ailments such as
type 2 diabetes [108], Alzheimer’s disease (AD) [109,110],
cardiovascular disease and stroke [111,112].
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Crataegus spp. (English name: Hawthorn; Family: Rosaceae).
The antioxidant activity of methanolic extracts from flowers
and fruits of the genus Crataegus spp. was demonstrated in
several stages of development [113]. Crataegus extracts are
also able to reduce the levels of plasma lipids, such as total
cholesterol, triacylglycerides, as also LDL and VLDL fractions
[114,115]. An alcoholic extract from Crataegus oxyacantha L.
(AEC) was found to exert similar cardioprotective effects as
captopril. AEC increased the activity of antioxidant enzymes
in mitochondria and prevented the decrease of Krebs’s cycle
enzymes induced by isoproterenol in rat heart. Pre-treatment
of AEC also successfully inhibited the increase in heart mito-
chondrial lipid peroxides, preventing mitochondrial lipid per-
oxidative damages [114,116]. The cardiotropic effect of
Crataegus spp. mainly derives from its ability to increase
membrane permeability for calcium as also through inhibition
of phosphodiesterase with the subsequent increase in intracel-
lular cAMP concentrations, culminating with the increase of
coronary and myocardial circulatory perfusion and reduction
in peripheral vascular resistance [52,53]. A Japanese clinical
trial involving 80 patients giving fruits and leaves from
Crataegus spp. highlighted the clinical improvement observed
in cardiac function, dyspnoea and oedema. On the other hand,
a German clinical study including 60 patients with stable ang-
ina pectoris receiving 60 mg hawthorn three times a day
showed increased coronary perfusion and economized myocar-
dial oxygen consumption [52]. Crataegus oxycantha extract
has shown to exhibit promising effects in preventing ischae-
mia-reperfusion injury. Crataegus extract (100 mg/kg b.w.)
significantly reduced creatine kinase activity and infarct size
in an in vivo rat model of acute myocardial infarction [114].
The study further elucidated that Crataegus extract was cap-
able of attenuating the phosphatase and tensin homolog
(PTEN) activities, chromosome deletions, up-regulation of
phospho-Akt and c-Raf levels in the heart. The experimental
research suggests that Crataegus extract prevents apoptosis
caused by myocardial ischaemia-reperfusion through regula-
tion of HIF-1 and Akt signalling pathways [114,117]. In a
study carried out by Hwang et al. (2017), a mixture of Panax
ginseng Meyer and Crataegus pinnatifida (GC) could exert
protective activities against skin ageing in human dermal
fibroblasts (HDF) under UV-B irradiation through elevating
the expression of procollagen type I and decreasing the secre-
tion of matrix metalloproteinase-1 [118]. Also, the cellular
antioxidant activity of C. pinnatifida (Chinese hawthorn) was
reported as being derived from the interaction between pheno-
lic compounds with other phytochemicals [113,119,120].
Moreover, the anti-inflammatory activity of extracts from
Crataegus azarolus L. seems to be regulated by their remark-
able antioxidant activities, through preventing pro-inflamma-
tory cytokines production, as well as by increasing the
secretion of anti-inflammatory cytokines [121]. In another
study, it was also demonstrated that the microcapsules contain-
ing procyanidins from hawthorn bark, as also the extract of
procyanidins exerted valuable antioxidant and anti-inflamma-
tory activities, suggesting their future application in dietary
and pharmaceutical products, and even as ingredients for
functional foods formulation [122]. Moreover, hawthorn
extract exerted prominent effects on alveolar bone loss and
periodontal inflammation, through modulation of total oxidant
status, oxidative stress index and total antioxidant status, in
rats with systemic periodontal disease [123]. As many edible
or pharmaceutical plants, also Crataegus genus is widely used
in many ageing-related disorders, such as diabetes [124], brain
damage following stroke [125] and cardiovascular function
[126,127].
Cynara scolymus L. (English name: Artichoke; Family:
Asteraceae).
Artichoke (Cynara scolymus L.) is a Mediterranean edible
vegetable, which is known to be rich in natural antioxidants,
among them hydroxycinnamic acids, vitamin C and flavones
[128,129]. The herbal formulation from this plant is com-
monly indicated as primary health care for different purposes
[130]. It was reported that artichoke exerted a considerable
improvement in GPx activity in erythrocytes from a rat model
[128]. Also, artichoke could decrease the levels of 2-aminoadi-
pic semialdehyde, a biomarker of protein oxidation present in
plasma proteins and haemoglobin [128]. Zapolska-Downar
et al. [131] demonstrated that artichokes exerted protective
actions against oxidative stress-resulted through oxidative
LDL and inflammatory regulators in preventing atherogenesis
in cultured monocytes and endothelial cells. The study showed
that both aqueous and ethanolic extracts from artichoke at
50 lg/mL inhibited oxidative stress-induced by oxidative LDL
in 15% and 29%, respectively. Therefore, it was suggested
that artichoke extract can be a potent therapeutic factor for
atherosclerosis by lowering the rates of LDL oxidation [131].
On the other hand, biosynthesis of cholesterol from 14C-acet-
ate in primary cultured rat hepatocytes in a concentration-
dependent biphasic manner could be inhibited by a dried aque-
ous extract from artichoke leaves (ratios 4.5:1), being observed
a moderate control (around 20%) from 0.007 to 0.1 mg/mL
and greater inhibition at 1 mg/mL (80%) [132,133]. Moreover,
the replacement of 14C-acetate with a 14C-mevalonate largely
prevented the inhibitory effects of the extracts, indicating inhi-
bition of the activity of hydroxyl-methyl-glutaryl-CoA-reduc-
tase (replacement of an acetate substituent with mevalonate
was followed by tracing radionuclides 14C activity) [133].
Thus, the induction of hydroxyl-methyl-glutaryl-CoA-reduc-
tase activity through insulin was easily inhibited by the extract
[133]. In past reports, Gebhardt et al. [134] found that cynaro-
side and its aglycone luteolin were the main responsible con-
stituents present in extract for enzyme inhibition. These data
seem to be confirmed in very recent reports [135]. The effects
of dried aqueous extract from artichoke leaves were evaluated
by two randomized, controlled clinical trials on the cholesterol
concentrations in 187 patients [136,137]. The first study com-
prised a randomized, double-blind, placebo-controlled pilot
study involving 44 healthy volunteers, and assessed the effect
of a crude extract on cholesterol levels. The study was con-
ducted by assigning randomized patients to receive either
640.0 mg of the extract or a placebo three times daily for
© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
MiniReview BRIEF CHALLENGES ON MEDICINAL PLANTS 545
12 weeks [138]. No significant effects on serum cholesterol
were found; however, in the subgroup analysis, significant
cholesterol-lowering effects were observed in individuals with
a total cholesterol level of >210 mg/dL (p < 0.022) [136].
The second study evaluated the efficacy and safety of a dried
aqueous extract of fresh artichoke by placebo-controlled inves-
tigation (25–35:1) [137]. Patients received either 1800 mg of
artichoke extract as coated tablets, each containing 450.0 mg
extract, or a placebo. One hundred and forty-three
hypolipoproteinaemia patients with initial total cholesterol
>7.3 mmol/L (>280 mg/dL) administered 1.8 g of a dried
extract of leaf per day or the placebo for 6 weeks. A statisti-
cally significant effect of dry artichoke extract on the changes
in total cholesterol and low-density lipoprotein cholesterol was
observed at the end of treatment when compared to the pla-
cebo (p = 0.0001). The patients treated with the extract previ-
ously shown to experience reductions in total cholesterol
levels by 18.5%, while only 8.6% reduction was observed in
the placebo group after 6 weeks of treatment [137]. The
decrease in low-density lipoprotein cholesterol by 63% was
also observed in the group treated with the extract while only
22.9% reduction in the placebo group. The ratio of low-den-
sity lipoprotein to high-density lipoprotein showed a decrease
of 20.2% in the group that received the extract and 7.2% in
the group that received placebo. No drug-related adverse
effects were reported [137]. Based on the latest findings, the
investigation of antioxidative phytochemicals from artichoke
has gained growing attention not only for their recognized
health-promoting activities but also due to the high contents of
caffeoylquinic acids and flavones present in capitula and
leaves [129].
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.
(English names: Siberian Ginseng, Eleuthero; Family:
Araliaceae).
Siberian ginseng is a highly valued woody medical product,
usually as a herbal shrub from the Araliaceae family with a
long history of use (by the Chinese population for over
2000 years) [139]. It contains different kinds of saponins such
as noroleanane, oleanane, lupane and 3,4-secolupane types,
according to the aglycone structure [140]. This medicinal plant
material exhibits noticeable anti-ageing effects [52], but adap-
togenic and antistress effects of Radix Eleutherococci have
also been related to metabolic control of energy, tissue pro-
teins and nucleic acids [141]. The intraperitoneal administra-
tion of a fluid extract from the roots (1.0 mL/kg body-weight)
enhanced the anabolic activity in male rats [95]. Meanwhile,
intragastric administration in mice of butanol extract from
roots (170 mg/kg b.w., daily, 6 days/week for 6 weeks)
enhanced the activity of oxidative enzymes and SOD in skele-
tal muscle, which consequently improved the rates of aerobic
metabolism [142,143]. Moreover, the roots of E. sentico-
sus are a natural source of flavonoids (hyperin, rutin, afzelin,
quercetin and kaempferol), phenols such as eleutherosides (lig-
nans, coumarins and phenylpropanoids derivatives), phenolic
and triterpenic acids, and even anthocyanins [144,145]. The
extracted compounds from fruits mainly contain phenolic
acids, eleutherosides (eleutherosides B and E), flavonoids, as
well as essential oil; also, dried fruits are a rich source of Ca,
Mg, Mn, Zn and Cu [144]. Flavonoids (quercetin, quercitrin
and rutin) have been mainly identified in leaves [144]. It has
also been reported that Siberian ginseng is an effective scav-
enger of peroxynitrite (ONOO), while to a Siberian ginseng
MeOH extract was found the maximum ferric reducing antiox-
idant power (FRAP) [146]. Also, it has been utilized in the
treatment of anaemia, inflammatory disorders and rheumatoid
arthritis [147].
Ginkgo biloba L. (English names: Gingko, Maidenhair tree;
Family: Ginkgoaceae).
Ginkgo is one of the oldest tree living species, widely applied
for therapeutic purposes in modern pharmacology. It is
reported to be effective in the treatment of peripheral arterial
disease and cerebral insufficiency in elderly [148,149]. Ginkgo
has been demonstrated to improve concentration and memory
deficits induced by peripheral arterial occlusive disease [150].
With the approval by the European Commission, ginkgo can
be used to relieve symptoms caused by organic brain dysfunc-
tion, such as tinnitus (vascular origin) and vertigo (vascular
origin). Ginkgo is also able to enhance blood flow and
decrease neutrophil infiltration, and therefore, it could be ben-
eficial for ischaemic dementia [151]. It has shown that mem-
brane is stabilizing and antioxidant activity of ginkgo may
increase the tolerance of cerebral hypoxia [53,152].
The standardized ginkgo leaf extracts are among the herbal
preparations that have undergone most extensive clinical
investigation. The effects of ginkgo extract in dementia have
been clinically tested mostly in trials involving patients with
cognitive deficiency, AD and/or multi-infarct dementia [153].
Ginkgo biloba extract (EGb 761) is prepared from dried
ginkgo leaves and has a standardized content of 22–27% fla-
vonol glycosides and 5–7% terpene trilactones. This extract is
used internally as a treatment for peripheral vascular and cere-
bral diseases, as well as to alleviate some of the ailments asso-
ciated with ageing, including dizziness, ringing in the ears and
short-term memory deterioration [150]. So far as is known,
the extract has only minimal side effects, even after prolonged
use [154,155]. Moreover, it has also been demonstrated that
EGb 761 displays an interesting effect as antiarrhythmic on
cardiac reperfusion-induced arrhythmias due to their antioxi-
dant activity [156]. Ginkgo could also prevent the mobile
phones-induced oxidative stress, through preservation of the
activity of antioxidant enzymes in brain tissue of rats [157].
Clinical use of G. biloba has been shown to effectively
improve the symptoms due to insufficient cerebral blood flow,
such as concentration and memory difficulties, absentminded-
ness, confusion, reduced physical performance, tiredness,
depressive mood, lack of energy, anxiety, tinnitus, dizziness
and headache [158]. Further, ginkgo has been shown to
improve the vasoregulation effects by increasing the blood
flow in arteries, capillaries and veins. Besides that, ginkgo has
also shown to exert rheological effects, metabolic effects,
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including minimizing disturbances of neurotransmitters,
increasing the tolerance to anoxia and preventing membrane
damage induced by free radicals [95]. On the other hand,
Zhou and Qi [152] revealed that G. biloba extract EGb-761
could attenuate the cerebral ischaemia-induced neuronal dam-
age by long-term pre-treatment in aged mice. Furthermore, it
was reported high antioxidant and lipid peroxidation inhibitory
effects to G. biloba leaf essential oil in various radical-scaven-
ging models [159]. Moreover, and not least important to point
out is that it has been revealed that polyphenols are one of the
main chemical constituents identified in G. biloba leaves with
antioxidant activities [160]. The analytical composition of
G. biloba extracts allowed recent authors to retrieve com-
pounds, such as bilobalide, ginkgolides A, B, C, quercetin,
kaempferol, isorhamnetin, rutin hydrate, quercetin-3-beta-D-
glucoside and quercitrin hydrate [161]. Many of them are clas-
sical flavonoids, which enable this extract to be active in
many ageing-related disorders [162–164].
Hippophae rhamnoides L. (English name: Sea Buckthorn;
Family: Eleagnaceae).
Hippophae rhamnoides, commonly called as sea buckthorn, is
the unique nitrogen-fixing deciduous shrub, native from Eur-
ope and Asia [165] and widely used for its medicinal and
nutritional properties [166,167]. All the plant parts contain
more than 190 bioactive substances, including flavonoids, phe-
nols, carotenoids, vitamins (A, E, K, C, B1, B2, B9), pig-
ments, fatty acids (x3, x 6, x 7, x 9), organic acids,
tocopherols, terpenes, sterols, tannins, minerals and other trace
elements with antioxidant properties [168,169]. The variability
in antioxidants, flavonoids and phenolics present in sea buck-
thorn seeds was observed across nine Himalayan populations’
underlines, highlighting the determinant effect of geographical
location and genetic factors to the chemical composition and
subsequent identification of the health-promoting responsible
compounds [170]. Leaves, seeds and fruits of sea buckthorn
have shown to exhibit diverse therapeutic and pharmacological
effects, including antioxidant, anti-inflammatory, immunomod-
ulatory, anti-atherogenic, cardioprotective, wound healing and
antistress properties [171]. It strengthens sight and inhibits
sclerosis and ageing process [52]. In fact, sea buckthorn leaf
alcoholic extract demonstrated a good ability to up-regulate
antigen presentation of macrophages in aged mice, exhibiting
their immune-boosting and anti-ageing effect [171,172]. Prepa-
rations of sea buckthorn are widely known for their cardiopro-
tective effects, which are well documented in Tibetan
traditional medical literature [173]. Some studies in human
and animals have been carried out to evaluate the effect of fla-
vonoids from sea buckthorn in cardiovascular diseases. In fact,
some flavonoids are well known to have positive ionotropic
effects, namely being able to improve the functioning of car-
diovascular system [174]. Flavonoids extracted from sea buck-
thorn leaves and fruits, known as total flavonoids of
Hippophae (THF), are a group of compounds containing seven
kinds of flavonoids. Among them, isorhamnetin and quercetin
were the main components, both exhibiting protective effects
on myocardial ischaemia and reperfusion, tumours, oxidative
injury and ageing process [171,175]. On the other hand, alco-
holic leaf extract and seed oil provided significant protection
against hypobaric hypoxia-stimulated through transvascular
fluid leakage in the lungs and brain of rats, through reduction
in vascular endothelial growth factor (VEGF) expression
[176]. Moreover, the pre-treatment with seed oil enhanced the
hypoxic tolerance as shown by the elevated survival time and
hypoxic gasping time, and declined plasma catecholamine
levels [171,176]. Hypoxic stress significantly enhances the
levels of malondialdehyde free radical production, accompa-
nied by a marked decrease in antioxidants levels, such as
GSH, GPx and SOD. Thus, in pre-treated animals with
H. rhamnoides, seed oil significantly reduced malondialdehyde
content and production of free radicals [177]. In C-6 glioma
cells hypoxia models, alcoholic leaf extract of H. rhamnoides
had similar effects: the exposure of cells to hypoxia for 12 hr
significantly increased the cytotoxic effect and coupled with
depolarization of mitochondrial transmembrane potential
[178]. The increase in nitric oxide (NO) and ROS production
and an increase in DNA damage were also observed during
hypoxia. Simultaneously, pre-treated cells with alcoholic leaf
extract of H. rhamnoides at a concentration of 200 mg/mL
significantly blocked the induced cytotoxicity, ROS produc-
tion, maintained the antioxidant levels, restored mitochondrial
integrity and prevented the occurrence of DNA damages
induced by hypoxia [179]. Free radicals have been associated
with the development of atherogenesis through oxidative pro-
cesses [175]. In fact, sea buckthorn is rich in polyunsaturated
fatty acids (PUFA), as well as lipophilic and aqueous antioxi-
dants. It was even found that antioxidants present in sea buck-
thorn juice ameliorate the main risk factors for coronary heart
disease (LDL oxidation, plasma lipids, plasma soluble cell
adhesion, platelet aggregation and protein concentration) in
humans [175,180]. The decrease in NO production induced by
lipopolysaccharides (LPS), the secretion of pro-inflammatory
cytokines, inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2) expression corroborates the anti-
inflammatory properties of the methanolic fraction obtained
from sea buckthorn, containing tannins, proteins and carbohy-
drate groups. Therefore, sea buckthorn seems to be an
immunomodulator which might even be effectively adminis-
tered as a therapeutic remedy for inflammatory disorders
[181]. Also, it was also shown that sea buckthorn extract
could protect oropharyngeal mucositis in rats induced by
methotrexate (MTX), through gene expression, biochemical
and histopathological tests, proposing this plant as an inexpen-
sive and effective natural product in controlling oropharyngeal
damages induced by MTX [182]. Clinical studies performed
using sea buckthorn showed their efficacy in cold stress, as
anti-hyperlipidaemic and even positive modulatory effects on
mental and general health status [183,184]. In a double-blind
clinical trial, 128 ischaemic heart patients were treated with
total flavonoids from sea buckthorn at 10 mg each time, three
times daily, for 6 weeks; a decrease in total cholesterol levels
and angina, and an improvement in cardiac function among
the patients that were given sea buckthorn were observed
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[185]. Not least interesting to highlight is that no harmful
effects of flavonoids from sea buckthorn were shown in renal
and hepatic functions. Besides, the mechanism of action seems
to be through decreasing the stress of cardiac muscle tissue
and by modulation of inflammatory mediators [185]. In labo-
ratory animal mouse models, sea buckthorn flavonoids were
capable of declining the formation of pathogenic thromboses
[171,185,186]. Moreover, flavonoid-enriched seed extract
could reduce high-fat-diet-induced obesity, hypertriglyceri-
daemia and hepatic triglyceride accumulation in C57BL/6
mice [187]. Therefore, it was revealed that this pathway regu-
lates the expression of both PPARc and PPARa genes, and
suppresses adipose tissue inflammation. Total flavones from
H. rhamnoides could prevent myocardium from ischaemia via
decreasing Bax protein expression, increasing Bcl-2 expression
and inhibiting cardiomyocyte apoptosis [188]. Moreover, total
flavones from H. rhamnoides could also reduce serum and
heart advanced glycation, and the content of end products
[189]. Some simple sea buckthorn-based formulas have been
used to treat cardiovascular diseases, by improvement cardiac
function and correcting blood circulation [185]. An immuno-
histochemical method was even used to assess the inhibitory
actions of total flavonoids from sea buckthorn on the induc-
tion of NF-jB through stretching cultured cardiac myocytes
[190]. The results supported that the blockage of NF-jB acti-
vation might be a potential access to the improvement in
myocardial function, and therefore, using sea buckthorn, it
would be better assessed the treatment of hypertension and
chronic cardiac insufficiency [190].
Panax ginseng Meyer (English name: Ginseng; Family:
Araliaceae).
Ginseng roots have been used for more than 2000 years and
recognized as a valuable ethnomedicinal herb in many Asian
countries, such as Japan, China and Korea [191]. Moreover,
ginseng is being extensively consumed both as a preventive
and therapeutic agent, against different kinds of diseases due
to their prominent anti-inflammatory, antioxidative, antidia-
betic and anticancer effects [192]. Their traditional use has
been divided into two main categories: short-term – to
improve the levels of histamine, the healing process, stress
resistance, vigilance and work efficiency in healthy individu-
als; and long-term – to improve well-being in debilitated and
degenerative conditions especially associated with old age
[52,53,153]. Also, ginsenoside Rc, one of the main pro-
topanaxadiol-type saponins extracted from Panax ginseng is
well known for their anticancer, anti-inflammatory, antiobesity
and antidiabetic activities. On the other hand, it was revealed
that their anti-inflammatory effects pass through suppressing
TANK-binding kinase, 1/IjB kinase (TBK1), e/interferon reg-
ulatory factor-3 (IRF-3) and p38/ATF-2 signalling [193]. As a
matter of fact, more than 28 ginsenosides were already
extracted from ginseng and might be associated with a broad
range of therapeutic actions at a level of central nervous sys-
tem (CNS), cardiovascular and endocrine systems. Notewor-
thy, ginseng has also been found to increase metabolism and
immune function and to exert anti-ageing and antistress activi-
ties [194]. It was also proved that several ginsenosides act as
non-organ-specific tumour suppressors as also improve the
learning and memory abilities in patients with AD [194]. In
another study, the anti-inflammatory activities of Korean red
ginseng (KRG)-derived components were evaluated, namely
water extract (KRG-WE), saponin fraction (KRG-SF) and
non-saponin fraction (KRG-NSF); the obtained outcomes indi-
cated that all of them exerted anti-inflammatory properties,
mainly through suppression of interferon regulatory transcrip-
tion factor 3 (IRF3) pathway [195]. It is well known that both
ginsenosides and ginseng exert protective action against vari-
ous neurodegenerative diseases on different stages of patho-
genesis and even symptoms. It was demonstrated in previous
studies that ginseng efficiently attenuates pathological changes
in cellular and animal models with AD, Parkinson’s dis-
ease (PD) or even Huntington’s diseases [196]. The beneficial
effects of ginseng on AD have been demonstrated both in
human and animal studies. In a Korean open-label trial,
patients with AD who had a dose of 9 g KRG/day in a period
of 12 weeks demonstrated significant improvement in clinical
test performance. In the ginseng group, the obtained scores for
mini-mental state examination (MMSE) and AD assessment
scale (ADAS) were significantly higher than those of the con-
trol group during the 12 weeks of ginseng consumption, and
even after discontinuing ginseng intake, a decline was
observed [32,33,196]. Furthermore, it has been observed in
several PD models that ginseng exert neuroprotective effects,
through multiple mechanisms, including as an antioxidant,
attenuates activation of caspase-3, suppresses activation of
stress kinases and may promote cell survival through elevation
of NGF mRNA expression [32]. Moreover, it may also protect
neurons in different disease stages; it interferes with stress
kinase signalling pathway and attenuates activation of cas-
pases, considered to be upstream and downstream events in
the apoptosis cascade, respectively; it also inhibits N-methyl-
D-aspartate (NMDA) receptor and therefore may slow down
the progression of neurodegeneration [32,192,197]. Overall,
ginseng is a well-known ‘anti-ageing herb’ due to its multidis-
ease stage intervention properties and multiple protective
mechanisms [32].
In another study, the in vitro antioxidative and anti-inflam-
matory effects of BIOGF1K, a compound K-rich fraction iso-
lated from the root of Panax ginseng, were accessed, being
observed a significant suppression of IKKb and TBK1,
involved respectively, in the transcriptional regulation of NF-
jB and IRF3 [198]. Moreover, the microbial transformation of
ginsenoside Rb1, Re and Rg1 increased their anti-inflamma-
tory properties via lipopolysaccharide-stimulated murine RAW
264.7 macrophages and even xylene-induced acute inflamma-
tory model of mouse ear oedema [199]. Further, in another
study, it was shown that pre-treatment with total saponins
extracted from ginseng remarkably inhibited NO production
through suppression of iNOS expression. Moreover, saponins
extracted from ginseng considerably decreased IL-1b produc-
tion both in LPS-induced TNF-a and in LPS-induced RAW
264.7 cells. It was reported that NF-jB could be translocated
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from the cytosol to the nucleus, while the pre-treatment with
saponins from ginseng could stimulate the sequestration of
NF-jB in the cytosol, through the inhibition of jB degrada-
tion, and therefore suggest that saponins extracted from gin-
seng could be promising therapeutic agents for the treatment
of inflammatory diseases associated with macrophage activa-
tion [200].
Rosmarinus officinalis L. (English name: Rosemary; Family:
Lamiaceae).
Rosmarinus officinalis, commonly known as rosemary,
belongs to the Lamiaceae family. It is a woody perennial
native plant from the Mediterranean countries, generally
spread in the European region. Hydroalcoholic extracts of
rosemary have been identified by the European Food Safety
Authority as safe [201], and therefore, their administration is
licensed as a natural preservative and antioxidant in foods.
Rosemary is used worldwide for several purposes, due to its
useful properties such as antispasmodic [202], anti-inflamma-
tory [203], antinociceptive [204], hepatoprotective [205] and
diuretic [206], directly connected with the active constituents
present in leaf extracts [207]. The most commonly identified
compounds are monoterpenes (essential oils), diterpenic phe-
nols (carnosol, carnosic acid, rosmanol, isorosmanol and
epirosmanol), triterpene acids and flavonols (oleanolic acid,
ursolic acid and betulinic acid) and phenolic acids (rosmarinic
acid) [207–210]. Carnosic and rosmarinic acids, as well as
carnosol, are the most important and potent antioxidant com-
pounds present in rosemary, being useful as protectors against
free radicals [211–214]. Besides, the hydroalcoholic extract of
rosemary leaves could inhibit the activity of acetyl-
cholinesterase (AChE) and butyrylcholinesterase (BChE),
leading to an improvement of impaired memory in rats [215].
Also, rosemary polyphenols increased cholinergic activities in
PC12 cells due to PI3K/Akt and ERK1/2 pathways [216,217].
Therefore, cholinergic activities of rosemary extracts play an
important contribution in pain signalling via cholinergic sys-
tem regulation [218]. The selective regulators of a7 [219] and
a9a10 [220] nAChR subtypes could alleviate nerve trauma-
stimulated pain in rats and inhibit nervous system derange-
ment that underlies neuropathies. Moreover, this plant also
exhibits anti-ageing effect [52], acting the diterpenoids carno-
sic acid, carnosol, rosmanol and epirosmanol as efficient inhi-
bitors of superoxide anion production in the xanthine/xanthine
oxidase system. At concentrations of 3–30 lM, these diterpe-
nes completely inhibited mitochondrial and microsomal lipid
peroxidation induced by NADH or NADPH oxidation. Fur-
ther, carnosic acid also protects red cells against oxidative
haemolysis. Therefore, these phenolic diterpenes have shown
to be effective in protecting biological systems against oxida-
tive stress [213,221]. Finally, the ethanolic extract from rose-
mary and specifically rosmarinic acid are well recognized to
be effective in inflammatory disorders and pain relief, mainly
through regulation of neuroinflammation, suggesting their
potential application in different neurological disorders associ-
ated with inflammation [222].
Schizandra chinensis Baill (English name: Schisandra;
Family: Schizandraceae).
Schizandra is a plant species whose fruits have been widely
used in traditional and modern Chinese medicine [223]. Its
fruits present a rich chemical composition, in which dibenzo
[a,c]cyclooctadiene lignans are the most important components
[224]. The plant material has a potent anti-ageing activity
being applied in PD [154,223]. Both schisandrol and schisan-
drin B, at 1.0 mmol/L, inhibited gossypol-induced superoxide
anion generation in rat liver microsomes [224]. Specifically,
schisandrin B suppressed in vitro lipid peroxidation induced
by carbon tetrachloride in hepatocytes, while schisandrol scav-
enged oxygen radicals in human neutrophils, induced by
tetradecanoylphorbol acetate [82,225]. Furthermore, treatment
with schisandrol, schisandrin C and schisandrin B, at
1.0 mmol/L, inhibited lipid peroxidation in rat liver micro-
somes [82]. The release of glutamate pyruvate transami-
nase (GPT) and lactate dehydrogenase was also reduced,
thereby increasing hepatocyte viability and integrity of hepato-
cyte membrane [226]. Schisandrin B, at 10 mmol/L, inhibited
NADPH oxidation in mouse liver microsomes incubated with
carbon tetrachloride [227,228] while at 110.0 lmol/L inhibited
oxidation of erythrocyte membrane lipids induced by ferric
chloride in vitro [225,229]. On the other hand, the inhibitory
effects of schisandra extract on acne-related inflammation and
UV-B-irradiated photo ageing revealed that it could dramati-
cally alleviate the inflammatory responses in HDF cells, indi-
cating its promising effects as a potent and efficient agent for
acne therapy and photoaging prevention [230]. Also, the
highly oxygenated triterpenoid schinchinenlactone D, isolated
from roots of schisandra, demonstrated prominent anti-inflam-
matory properties [231]. Moreover, it was also demonstrated
that plant-derived essential oil from schisandra pulps and
seeds, rich in monoterpenes and sesquiterpenes, present mod-
est antioxidant, antibacterial and cytotoxic activities [232]. On
the other hand, it has been reported that PPAR-c activation
could be regulated by schisandrin B (SchB), a dibenzocy-
clooctadiene lignan isolated from Schisandra chinensis, which
exerts anti-inflammatory action against LPS-stimulated BV2
microglial inflammation [233]. Moreover, SchB could inhibit
TNF-a and IL-8 production in LPS-induced human umbilical
vein endothelial cells and control LPS-stimulated VCAM-1
and ICAM-1 expression; SchB also inhibited NF-jB activation
induced by LPS and improved Nrf2 and HO-1 expression in a
concentration-dependent manner. Further, the inhibition of
TNF-a and IL-8 production via SchB could block by transfec-
tion with Nrf2 siRNA [233]. On the other hand, it was
reported that schinlignan D and (+)-schisandrol B from
Schisandra chinensis fruits could suppress PCSK9 protein
expressions, also exerting a critical role in LDL cholesterol
metabolism, mainly acting as LDL receptor degradator [234].
In another study, selenizing schisandra polysaccharide (sSCP)
demonstrated significant antioxidant activity in hepatocyte
from chicken embryo [235]. The sSCP acted as a selenium-
rich source of natural antioxidants that could dramatically give
hepatocyte protection due to oxidative damage induced by
hydrogen peroxide (H2O2). The protective effect might be
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attributed to regulation of the expression of protein in mito-
chondrion dependence apoptotic and MAPKs signalling path-
ways. Also, kadsuphilactone B, a nortriterpenoid extracted
from schisandra fruit, stimulates caspase-dependent apoptosis
in human cancer cells via the modulation of Bcl-2 family pro-
tein and MAPK signalling [236]. In the same line, it has been
demonstrated that lignans from petroleum ether fraction of
schisandra fruits alleviate cognition disorders and attenuate
brain oxidative damage stimulated by D-galactose in rats, sug-
gesting their potential application in ageing-associated neu-
rodegenerative diseases [237]. Schisandra extract has also
shown to reduce non-alcoholic fatty liver by inhibiting ER
stress in tunicamycin- or palmitate-treated HepG2 cells
in vitro. Meanwhile, Schisandra inhibited alcoholic fatty liver
accumulation in tunicamycin-injected mice or high-fat diet
(HFD) in obese mice by inhibiting glucose-regulated C/EBP
homologous protein (CHOP), X-box-binding protein-1 (XBP-
1) and protein 78 (GRP78). In overall, Schisandra could be a
potential protective agent against ER stress-induced human
diseases [238].
Seaweeds
Seaweeds are rich sources of minerals (including sodium, cal-
cium, potassium and phosphorus) and vitamins (such as A,
B1, B2, B5, B9, B12, C, D and E vitamins) [239], also repre-
senting one of the primary sources of essential amino acids
for health maintenance [240]. Moreover, there are more than
54 different trace elements in seaweeds, which are essential
for human physiological haemostasis, and this content is sig-
nificantly higher than what is present in terrestrial plants,
including vegetables [240,241]. Seaweeds are traditionally
used in Chinese medicine in the treatment of a wide variety of
disorders, among them enlarged thyroid glands, liver diseases,
cysts, swelling and phlegm. A study using 13C-NMR spec-
troscopy revealed that the primary antioxidant active com-
pound present in acetone extract from Hijikia fusiformis, a
common edible seaweed, is fucoxanthin [242]. In fact, fucox-
anthin is the main marine carotenoid present in brown sea-
weeds that can protect against oxidative stress stimulated by
UV-B radiation [243]. Moreover, two metabolites from fucox-
anthin, namely fucoxanthinol and halocynthiaxanthin, have
shown to exert numerous biological functions, among them
antioxidant effects, acting both as free radical scavengers and
singlet oxygen quenchers [244]. Also, fucoxanthin isolated
from Myagropsis myagroides, widely known as brown algae,
can suppress both iNOS and COX-2 mRNA expression, at the
same time that decreases the release of TNF-a, IL-1b and IL-
6, and even mRNA expression levels, in a dose-dependent
manner. Besides, fucoxanthin could also inhibit oxidative
stress stimulated by retinol deficiency, through regulation of
Na+Ka+-ATPase, and CAT and glutathione-S-transferase
enzymes activity, in rats both at the tissue and microsomal
levels [245]. All these facts suggest that fucoxanthin could be
a promising therapeutic remedy to apply in different kinds of
inflammatory diseases [240,246]. Promissory antioxidant
effects have also been stated by seven seaweeds from Madeira
Archipelago, widely known as chlorophyte (Ulva lactuca),
phaeophyte (Zonaria tournefortii) and rhodophytes (Galaxaura
rugosa, Asparagopsis taxiformis, Nemalion elminthoides,
Grateloupia lanceola, and Chondrus crispus) [247]. More-
over, Porphyra tenera, which are the most common edible red
seaweeds in Asia, have shown to exhibit potent antioxidant
activity, suggesting their potential use for cosmetic and food
industries [248].
Grapes, Red Wine and Resveratrol
Resveratrol, notoriously present in grapes, red wine, peanuts,
berries and other traditional medicines, [249] is a stilbene
with presumptive anti-ageing properties [250,251]. The effect
of this specific phytoalexin ameliorated cognitive impairment
and neurodegeneration subsequent to senescence [252,253]
and prevented further manifestations related to ageing
[254,255]. In AD, experiments on mesenchymal stem cell
transplantation using human umbilical cord-derived mesenchy-
mal stem cells (hUC-MSCs) in a mouse model showed that
the cotreatment with resveratrol enhanced the expression of
the survival markers SIRT1, PCNA, p53, ac-p53, p21 and
p16, promoting neurogenesis in hippocampal regions and
inhibiting apoptosis [256]. The role of resveratrol in AD has
been extensively reviewed [257–259]. This phenolic com-
pound is also able to further prevent neurodegenerative dis-
eases such as dementia [260] and PD [261]. In fact, wine
stilbenes are formidable antioxidant molecules able to coun-
teract metabolic disease and cardiovascular disorders [262–
264]. To date, research has strong evidence to support the
idea that a single dose of resveratrol can induce beneficial
physiological responses and improve clinical outcomes from
ageing-related pathologies [265]. Recently, it has been demon-
strated that resveratrol alleviates ageing-associated metabolic
phenotypes through the restriction of camp phosphodiesterases
[266].
Concluding Remarks
Although the comprehension about the detailed ageing-related
mechanism is still limited, several cellular and molecular path-
ways were already stated as being involved in this process.
Up to the moment, cellular ageing can be stimulated through
induction of tumour suppressor genes, telomere shortening and
oncogenes, chronic inflammation, oxidative stress and ultravi-
olet irradiation. In fact, it has been documented that cells are
undergoing ageing present increased levels of intracellular
ROS, an over-expression of NF-jB transcription and hyperac-
tivity of the inflammatory cytokines, such as TNF-a, IL-1b
and IL-6. Therefore, chronic inflammatory process and oxida-
tive stresses may be conceived as the most important risk fac-
tors underlying age-related diseases and ageing process. On
the other hand, natural matrices have received growing atten-
tion while promising sources of biologically active compo-
nents, among them antioxidant and anti-inflammatory
molecules. Several investigations have been performed evalu-
ating some plants, vegetables, fruits and even seaweeds,
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widespread in nature, presenting all of them a rich chemical
composition in terms of antioxidants sources, including vitamin
A, C, E, carotenoids, phenolic compounds and other bioactive
molecules that have a great ability to prevent free radical dam-
age and to reduce the risk of chronic diseases. Many flavonoids
and phenolic acids can prevent ageing-related damage, through
their interaction with the signalling machinery and modulate cell
survival. Interestingly, the most common molecular target of fla-
vonoids and phenolic acids contained in the aforementioned
plant extracts is the Keap1-Nrf2-ARE regulatory pathway.
Inducers of the indirect antioxidant defence system, they are
either Michael acceptors or can be metabolized to reactive elec-
trophiles capable to alkyl cysteine thiols in Keap1 and/or can
induce the formation of cytosolic ROS resulting in the release of
Nrf2, followed by activation of transcription gene through the
ARE, leading to the formation of cytoprotective proteins. For
certain aspects, this is considered the most important mechanism
for controlling oxidative stress in the human body, and not so
much the direct antioxidant effect, which is the main mechanism
of action that has been focused in this Mini Review. Besides,
the major flavonoids, such as quercetin, luteolin, apigenin,
which can be widely found in medicinal plants, also exert their
activity through counteracting apoptosis in healthy cells and
promote the same in cancer cells, inhibiting NF-jB and activat-
ing FOXO-3, AMPK/mTOR and sirtuin signalling (pro-survival
and anti-ageing). All these actions culminate with the regulation
of metabolism, energetic balance, immunity and senescence,
also promoting autophagy rather than apoptosis. These bioactive
molecules are better represented and bioavailable in plant-
derived food products rather than nutraceuticals (diet supple-
mentation), a direct reason to promote healthy dietary habits
rather than supplementation panels. Anyway, and despite the
existence of a huge deal of reports showing newly published
evidence about anti-ageing plant extracts, further insights are
needed to improve the knowledge and to incite the use of these
natural compounds.
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